Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q4 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Achieve Life Sciences Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast.
Achieve Life Sciences Inc. (ACHV)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Leucadia National Ian Cumming And Joseph Steinberg | 12,572 | $36,962 | -26% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.89 | 10,000 | $28,887.00 | 10,000 | 2025-03-17 | Filing | |
| $2.86 | 10,000 | $28,598.00 | 60,876 | 2025-03-17 | Filing | |
| $4.59 | 10,000 | $45,850.00 | 38,501 | 2024-03-04 | Filing | |
| $4.59 | 10,000 | $45,850.00 | 76,724 | 2024-03-04 | Filing | |
| $5.50 | 5,000 | $27,500.00 | 66,730 | 2023-05-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.92 | 50,060 | $146,175.20 | 127,940 | 2025-09-18 | Filing | |
| $2.92 | 129,501 | $378,142.92 | 228,875 | 2025-09-18 | Filing | |
| $2.77 | 14,070 | $38,973.90 | 32,694 | 2025-09-04 | Filing | |
| $2.77 | 139,858 | $387,406.66 | 315,142 | 2025-09-04 | Filing | |
| $2.77 | 27,629 | $76,532.33 | 115,585 | 2025-09-04 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,204,714 | $6,481,859 | 0% | |
| 2. | 1,184,512 | $3,482,465 | 0.05% | |
| 3. | 728,448 | $2,141,637 | 0% | |
| 4. | 326,270 | $959,234 | 0% | |
| 5. | 316,177 | $929,560 | 0% |
News See All
Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory
We came across a bullish thesis on Achieve Life Sciences, Inc. on Hunterbrook’s Substack. In this article, we will summarize the bulls’ thesis on ACHV.
FDA Accepts Achieve Life Sciences, Inc. (ACHV) NDA Application for Cytisinicline in Smoking Cessation
Achieve Life Sciences Inc. (NASDAQ:ACHV) is one of the Canadian penny stocks to buy right now. Lake Street’s Thomas Flaten maintained a Buy rating on Achieve Life Sciences Inc.
13 Best Canadian Penny Stocks to Buy Right Now
Penny and small-cap stocks have lagged the overall market amid heightened focus on large caps during the artificial intelligence boom.
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q3 2025 Earnings Call Transcript
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q3 2025 Earnings Call Transcript November 6, 2025Achieve Life Sciences, Inc. misses on earnings expectations.
Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory
This stock is one of several featured in our latest research.
10 High-Potential Small-Caps With Market Cap Under $1B.
Small-cap stocks often fly under the radar of institutional investors, yet they can deliver outsized returns for those willing to look beyond the headlines.
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q2 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Achieve Life Sciences Second Quarter 2025 Earnings Conference Call and Webcast. As a reminder, this conference is being recorded.
Should You Hold Achieve Life Sciences (ACHV)?
Rogue Funds, an investment management company, released its first quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund depreciated 12.4% net of fees in the quarter.
Omnicom, Achieve Life Sciences Partner for AI-Driven Launch of New Nicotine Dependence Treatment
Omnicom Group Inc. (NYSE:OMC) is one of the best high short interest stocks with huge upside potential. On June 26, Achieve Life Sciences Inc.
Hedge Fund Resource Center